You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Hereditary Cancer Testing Eligibility Criteria: Version 3

Version: 3 oct 2022
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
Hereditary Cancer Testing Eligibility Working Group

Guideline Objective 

To facilitate clinically appropriate access to hereditary cancer testing for individuals based on their personal and/or family history of cancer, with considerations for tumour pathology and decision support for treatment. 

Patient Population

Individuals with, or at risk for, a hereditary cancer syndrome

Intended Guideline Users

Genetics Professionals

pdf download Full Report (PDF) (557.67 Ko)